Assess The Efficacy, Safety, And Tolerability Of An Injection Treatment In Chronic Obstructive Pulmonary Disease
Study To Assess The Efficacy, Safety, And Tolerability Of Drug vs Placebo In Chronic Obstructive Pulmonary Disease
This is a study to evaluate the efficacy of an injection treatment compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with moderate-to-severe COPD (Chronic Obstructive Pulmonary Disease).
Carolina Clinical Research is currently seeking study participants 40 to 85 years of age with a current COPD diagnosis of at least one year, with a smoking history of greater than or equal to 10 years, but who are not currently smoking.
This study is currently sponsored by Sanofi, in collaboration with Regeneron Pharmaceuticals.